Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Works of Marlene E. Haffner being referenced
Orphan drug product regulation – United States
2002
Orphan Products: Origins, Progress, and Prospects
1991
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marlene E. Haffner | 54 | 151 | 81 | 73 | 23 | 299 | |
| Josep Torrent-Farnell | 28 | 159 | 32 | 56 | 10 | 241 | |
| Eline Picavet | 21 | 204 | 44 | 82 | 18 | 283 | |
| Tamás Zelei | 17 | 127 | 44 | 45 | 26 | 317 | |
| Enrico Costa | 14 | 87 | 39 | 59 | 26 | 268 | |
| Ewa Stawowczyk | 11 | 134 | 87 | 44 | 23 | 312 | |
| Donato Bonifazi | 32 | 70 | 22 | 151 | 24 | 280 | |
| Anna Kole | 147 | 42 | 129 | 27 | 10 | 317 | |
| Erica Pitini | 61 | 73 | 151 | 33 | 30 | 297 | |
| Toon van der Gronde | 44 | 57 | 15 | 35 | 22 | 325 | |
| Hilde Stevens | 47 | 92 | 11 | 18 | 20 | 240 |
All Works
Loading papers...